🔎 Trials Near Me

Home › Crohn's Disease › Texas › San Antonio

Crohn's Disease clinical trials in San Antonio, TX

15 studies for Crohn's Disease are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

RecruitingPhase 3
  • Southern Star Research Institute ( Site 0299), San Antonio
All ages · All sexes · Updated Oct 2, 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RecruitingPhase 3
  • Southern Star Research Institute ( Site 5000), San Antonio
Ages 16 to 80 · All sexes · Updated Oct 2, 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RecruitingPhase 2
  • Southern Star Research Institute /ID# 280822, San Antonio
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07697456

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RecruitingPhase 2
  • Sun Research Institute /ID# 266723, San Antonio
  • Southern Star Research Institute /ID# 278124, San Antonio
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Gastroenterology Research of America, LLC, San Antonio
  • Southern Star Research Institute, LLC, San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2/3
  • Southern Star Research Institute, LLC, San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2
  • Southern Star Research Institute, LLC, San Antonio
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RecruitingPhase 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184944

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RecruitingPhase 2
  • Southern Star Research Institute, San Antonio
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RecruitingPhase 2
  • Southern Star Research Institute, San Antonio
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RecruitingPhase 4
  • Gastroenterology Research of San Antonio, LLC, San Antonio
  • Southern Star Research Institute, LLC., San Antonio
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06045754

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

RecruitingPhase 3
  • Southern Star Research Institute, LLC, San Antonio
Ages 18 to 65 · All sexes · Updated May 27, 2026 · NCT06227910

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

RecruitingPhase 2
  • Southern Star Research Institute, LLC, San Antonio
Ages 18 to 75 · All sexes · Updated Apr 27, 2026 · NCT06456593

About Crohn's Disease

Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.

More about Crohn's Disease on MedlinePlus

Crohn's Disease trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.